AGP Executive Report
Last update: 9 hours agoGLP-1 Safety Watch: A new study presented at ENDO 2026 links GLP-1 use in older adults and people with type 2 diabetes—especially when combined with multiple blood-pressure meds—to higher rates of dizziness, fainting, falls, and other hypotension-related events. Medical Devices & Patents: Hologic, based in Marlborough, won largely in a European patent dispute against Siemens Healthineers over breast tomosynthesis imaging technology, with the court rejecting Siemens’ attempt to revoke the patent. Infectious Disease: Massachusetts General Hospital researchers warn that two newly approved oral antibiotics for uncomplicated gonorrhea could still face rapid resistance if used broadly, echoing the cycle seen with past first-line treatments. Local Health & Access: Cambridge Health Alliance plans to reopen a birth center after a six-year hiatus, aiming to expand maternal care options. Public Health & Policy: The Massachusetts House passed a $3.5 billion environmental bond bill focused on climate resilience, clean water and air, and streamlining permitting for key projects. Community Health Support: The Cummings Foundation awarded the Metrowest Women’s Fund a $25,000 grant (renewable up to three years) to expand mental health, safety, and education access for women and girls. Workforce & Caregiving: A new report highlights the worsening U.S. healthcare workforce crisis, while another story points to the growing caregiving burden on families.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.